Effects of concentric and repeated eccentric exercise on muscle damage and calpain-calpastatin gene expression in human skeletal muscle.
The purpose of this study was to compare the responsiveness of changes in Ca(2+)-content and calpain-calpastatin gene expression to concentric and eccentric single-bout and repeated exercise. An exercise group (n = 14) performed two bouts of bench-stepping exercise with 8 weeks between exercise bouts, and was compared to a control-group (n = 6). Muscle strength and soreness and plasma creatine kinase and myoglobin were measured before and during 7 days following exercise bouts. Muscle biopsies were collected from m. vastus lateralis of both legs prior to and at 3, 24 h and 7 days after exercise and quantified for muscle Ca(2+)-content and mRNA levels for calpain isoforms and calpastatin. Exercise reduced muscle strength and increased muscle soreness predominantly in the eccentric leg (P < 0.05). These responses as well as plasma levels of creatine kinase and myoglobin were all attenuated after the repeated eccentric exercise bout (P < 0.05). Total muscle Ca(2+)-content did not differ between interventions. mRNA levels for calpain 2 and calpastatin were upregulated exclusively by eccentric exercise 24 h post-exercise (P < 0.05), with no alteration in expression between bouts. Calpain 1 and calpain 3 mRNA did not change at any specific time point post-exercise for either intervention. Our mRNA results suggest a regulation on the calpain-calpastatin expression response to muscle damaging eccentric exercise, but not concentric exercise. Although a repeated bout effect was demonstrated in terms of muscle function, no immediate support was provided to suggest that regulation of expression of specific system components is involved in the repeated bout adaptation.
Vissing
Kristian
K
Department of Sport Science, University of Aarhus, Dalgas Avenue 4, 8000 Aarhus C, Denmark. vissing@idraet.au.dk
Overgaard
Kristian
K
Nedergaard
Anders
A
Fredsted
Anne
A
Schjerling
Peter
P
D000222:Adaptation, Physiological; D000328:Adult; D002118:Calcium / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D002154:Calpain / Q000235:genetics / Q000378:metabolism*; D003402:Creatine Kinase / Q000097:blood; D015444:Exercise; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000235:genetics; D009124:Muscle Proteins / Q000378:metabolism; D053580:Muscle Strength; D009211:Myoglobin / Q000097:blood; D010146:Pain / Q000378:metabolism; D010147:Pain Measurement; D052097:Quadriceps Muscle / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D013997:Time Factors; D015854:Up-Regulation
D002135:Calcium-Binding Proteins; D009124:Muscle Proteins; D009211:Myoglobin; D012333:RNA, Messenger; C033668:calpastatin; D003402:Creatine Kinase; C105884:CAPN3 protein, human; D002154:Calpain; C484806:CAPN1 protein, human; C569870:CAPN2 protein, human; D002118:Calcium